annual SGA:
$264.12M-$1.42M(-0.54%)Summary
- As of today (July 1, 2025), TVTX annual SGA is $264.12 million, with the most recent change of -$1.42 million (-0.54%) on December 31, 2024.
- During the last 3 years, TVTX annual SGA has risen by +$137.84 million (+109.15%).
- TVTX annual SGA is now -0.54% below its all-time high of $265.54 million, reached on December 31, 2023.
Performance
TVTX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$72.84M+$3.34M(+4.80%)Summary
- As of today (July 1, 2025), TVTX quarterly SGA is $72.84 million, with the most recent change of +$3.34 million (+4.80%) on March 31, 2025.
- Over the past year, TVTX quarterly SGA has increased by +$8.62 million (+13.41%).
- TVTX quarterly SGA is now at all-time high.
Performance
TVTX quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$5.65B-$226.71M(-4.18%)Summary
- As of today (July 1, 2025), TVTX TTM SGA is -$5.65 billion, with the most recent change of -$226.71 million (-4.18%) on March 31, 2025.
- Over the past year, TVTX TTM SGA has dropped by -$5.92 billion (-2243.38%).
- TVTX TTM SGA is now -4661528.19% below its all-time high of -$121.30 thousand.
Performance
TVTX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
TVTX Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.5% | +13.4% | -2243.4% |
| 3 y3 years | +109.2% | +55.7% | -4248.8% |
| 5 y5 years | +104.8% | +119.8% | -4608.4% |
TVTX Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.5% | +109.2% | at high | +39.0% | -78.3% | at low |
| 5 y | 5-year | -0.5% | +109.2% | at high | +294.2% | -240.6% | at low |
| alltime | all time | -0.5% | >+9999.0% | at high | >+9999.0% | <-9999.0% | at low |
TVTX Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $72.84M(+4.8%) | $272.73M(+3.3%) |
| Dec 2024 | $264.12M(-0.5%) | $69.50M(+5.9%) | $264.12M(+2.3%) |
| Sep 2024 | - | $65.62M(+1.3%) | $258.21M(-0.8%) |
| Jun 2024 | - | $64.78M(+0.9%) | $260.39M(-1.3%) |
| Mar 2024 | - | $64.22M(+1.0%) | $263.81M(-0.7%) |
| Dec 2023 | $265.54M(+34.4%) | $63.59M(-6.2%) | $265.54M(+2.5%) |
| Sep 2023 | - | $67.80M(-0.6%) | $259.04M(+6.3%) |
| Jun 2023 | - | $68.20M(+3.4%) | $243.66M(+6.7%) |
| Mar 2023 | - | $65.95M(+15.5%) | $228.44M(+9.2%) |
| Dec 2022 | $197.52M(+56.4%) | $57.09M(+8.9%) | $209.27M(+22.6%) |
| Sep 2022 | - | $52.42M(-1.1%) | $170.66M(+10.6%) |
| Jun 2022 | - | $52.98M(+13.2%) | $154.31M(+13.2%) |
| Mar 2022 | - | $46.79M(+153.2%) | $136.29M(+7.9%) |
| Dec 2021 | $126.28M(-7.0%) | $18.48M(-48.8%) | $126.28M(-12.0%) |
| Sep 2021 | - | $36.06M(+3.1%) | $143.55M(+3.0%) |
| Jun 2021 | - | $34.97M(-4.9%) | $139.43M(-0.0%) |
| Mar 2021 | - | $36.78M(+2.9%) | $139.44M(+2.7%) |
| Dec 2020 | $135.80M(+5.3%) | $35.74M(+11.9%) | $135.80M(+6.4%) |
| Sep 2020 | - | $31.95M(-8.6%) | $127.59M(+1.7%) |
| Jun 2020 | - | $34.97M(+5.5%) | $125.42M(-3.1%) |
| Mar 2020 | - | $33.14M(+20.4%) | $129.42M(+0.4%) |
| Dec 2019 | $128.95M(+24.4%) | $27.53M(-7.5%) | $128.95M(+1.2%) |
| Sep 2019 | - | $29.78M(-23.6%) | $127.40M(+3.0%) |
| Jun 2019 | - | $38.97M(+19.3%) | $123.72M(+12.6%) |
| Mar 2019 | - | $32.67M(+25.8%) | $109.86M(+6.0%) |
| Dec 2018 | $103.65M(-0.3%) | $25.98M(-0.5%) | $103.65M(-1.2%) |
| Sep 2018 | - | $26.11M(+4.0%) | $104.95M(+1.2%) |
| Jun 2018 | - | $25.10M(-5.2%) | $103.69M(-3.5%) |
| Mar 2018 | - | $26.47M(-3.0%) | $107.43M(+3.2%) |
| Dec 2017 | $103.96M | $27.27M(+9.7%) | $104.08M(+1.0%) |
| Sep 2017 | - | $24.85M(-13.8%) | $103.03M(-3.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | $28.84M(+24.7%) | $106.86M(+5.6%) |
| Mar 2017 | - | $23.11M(-11.9%) | $101.22M(+4.1%) |
| Dec 2016 | $97.15M(+22.1%) | $26.23M(-8.5%) | $97.23M(+3.8%) |
| Sep 2016 | - | $28.68M(+23.6%) | $93.69M(+7.3%) |
| Jun 2016 | - | $23.20M(+21.3%) | $87.32M(+4.2%) |
| Mar 2016 | - | $19.13M(-15.7%) | $83.81M(+5.4%) |
| Dec 2015 | $79.54M(+33.4%) | $22.68M(+1.7%) | $79.54M(+6.9%) |
| Sep 2015 | - | $22.31M(+13.3%) | $74.40M(+7.1%) |
| Jun 2015 | - | $19.69M(+32.6%) | $69.47M(+17.0%) |
| Mar 2015 | - | $14.86M(-15.3%) | $59.35M(-0.5%) |
| Dec 2014 | $59.65M(+237.2%) | $17.55M(+1.0%) | $59.65M(+20.8%) |
| Sep 2014 | - | $17.37M(+81.4%) | $49.40M(+38.1%) |
| Jun 2014 | - | $9.58M(-36.8%) | $35.78M(+16.8%) |
| Mar 2014 | - | $15.15M(+107.5%) | $30.64M(+77.9%) |
| Dec 2013 | $17.69M(-40.2%) | $7.30M(+94.4%) | $17.22M(+73.5%) |
| Sep 2013 | - | $3.75M(-15.5%) | $9.93M(+60.8%) |
| Jun 2013 | - | $4.44M(+157.2%) | $6.17M(+255.7%) |
| Mar 2013 | - | $1.73M(>+9900.0%) | $1.74M(>+9900.0%) |
| Dec 2012 | $29.59M(>+9900.0%) | - | - |
| Nov 2012 | - | $3200.00(+6.7%) | $13.00K(+1.6%) |
| Aug 2012 | - | $3000.00(0.0%) | $12.80K(0.0%) |
| May 2012 | - | $3000.00(-21.1%) | $12.80K(0.0%) |
| Feb 2012 | - | $3800.00(+26.7%) | $12.80K(+1.6%) |
| Feb 2012 | $12.80K(+0.8%) | - | - |
| Nov 2011 | - | $3000.00(0.0%) | $12.60K(-0.8%) |
| Aug 2011 | - | $3000.00(0.0%) | $12.70K(0.0%) |
| May 2011 | - | $3000.00(-16.7%) | $12.70K(0.0%) |
| Feb 2011 | $12.70K | $3600.00(+16.1%) | $12.70K(+39.6%) |
| Nov 2010 | - | $3100.00(+3.3%) | $9100.00(+51.7%) |
| Aug 2010 | - | $3000.00(0.0%) | $6000.00(+100.0%) |
| May 2010 | - | $3000.00 | $3000.00 |
FAQ
- What is Travere Therapeutics annual SGA?
- What is the all time high annual SGA for Travere Therapeutics?
- What is Travere Therapeutics annual SGA year-on-year change?
- What is Travere Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Travere Therapeutics?
- What is Travere Therapeutics quarterly SGA year-on-year change?
- What is Travere Therapeutics TTM SGA?
- What is the all time high TTM SGA for Travere Therapeutics?
- What is Travere Therapeutics TTM SGA year-on-year change?
What is Travere Therapeutics annual SGA?
The current annual SGA of TVTX is $264.12M
What is the all time high annual SGA for Travere Therapeutics?
Travere Therapeutics all-time high annual SGA is $265.54M
What is Travere Therapeutics annual SGA year-on-year change?
Over the past year, TVTX annual SGA has changed by -$1.42M (-0.54%)
What is Travere Therapeutics quarterly SGA?
The current quarterly SGA of TVTX is $72.84M
What is the all time high quarterly SGA for Travere Therapeutics?
Travere Therapeutics all-time high quarterly SGA is $72.84M
What is Travere Therapeutics quarterly SGA year-on-year change?
Over the past year, TVTX quarterly SGA has changed by +$8.62M (+13.41%)
What is Travere Therapeutics TTM SGA?
The current TTM SGA of TVTX is -$5.65B
What is the all time high TTM SGA for Travere Therapeutics?
Travere Therapeutics all-time high TTM SGA is -$121.30K
What is Travere Therapeutics TTM SGA year-on-year change?
Over the past year, TVTX TTM SGA has changed by -$5.92B (-2243.38%)